Earnings Feed
Start Free
BECTON DICKINSON & CO·4

Jul 22, 5:29 PM ET

Garrison Michael David 4

4 · BECTON DICKINSON & CO · Filed Jul 22, 2025

Insider Transaction Report

Form 4
Period: 2025-07-18
BECTON DICKINSON & COBDX
Garrison Michael David
EVP & Pres Med.Essntl&BioPharm
Transactions
  • Exercise/Conversion

    Common Stock

    2025-07-18$147.68/sh+6,360$939,245→ 11,247 total
  • Sale

    Common Stock

    2025-07-18$180.29/sh−1,184$213,463→ 4,888 total
  • Sale

    Common Stock

    2025-07-18$181.50/sh−1$182→ 4,887 total
  • Disposition to Issuer

    Common Stock

    2025-07-18$180.29/sh−5,175$933,001→ 6,072 total
  • Exercise/Conversion

    Stock Appreciation Rights

    2025-07-18−6,360→ 0 total
    Exercise: $147.68From: 2016-11-26Exp: 2025-11-26→ Common Stock (6,360 underlying)
Footnotes (1)
  • [F1]The stock appreciation rights vested in four annual installments beginning one year after grant.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES